Technology
Health
Pharmaceutical
Zymeworks
$24.319876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$24.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
$0.00 (0.00%) Today
$0.00 (0.00%) As of 4:30 PM EDT after-hours
Why Robinhood?
You can buy or sell Zymeworks and other stocks, options, ETFs, and crypto commission-free!
About ZYME
Zymeworks Inc., also called Zymeworks, is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. Read More The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
CEO
Employees
183
Headquarters
Vancouver, British Columbia
Founded
2003
Market Cap
779.10M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
318.22K
High Today
$24.50
Low Today
$23.78
Open Price
$24.39
Volume
117.01K
52 Week High
$25.71
52 Week Low
$10.72
Collections
Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2017 IPO
Canada
North America
ZYME News
Price Paid on Robinhood
60% Higher
Right Now
52 Week Low
$10.72
Average Price Paid
$15.15
52 Week High
$29.00
Analyst Ratings
88%
of 8 ratings
Buy
88%
Hold
13%
Sell
0%
ZYME Earnings
-$0.83
-$0.13
$0.58
$1.28
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 31, After Hours